Cavitation Technologies, Inc.
For the period ended Jun 30, 2025. Filed Sep 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 29, 2025
CVATStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THIS REPORT HAS BEEN SIGNED BELOW BY THE FOLLOWING PERSONS ON BEHALF OF THE REGISTRANT AND IN THE CAPACITIES AND ON THE DATES INDICATED
| SIGNATURE | TITLE | DATE |
|---|---|---|
| /s/ N. Voloshin | President; Member of Board of Directors | September 29, 2025 |
| N. Voloshin | (Principal Executive Officer) | |
| /s/ N. Voloshin | Chief Financial Officer | September 29, 2025 |
| N. Voloshin | (Principal Financial Officer) | |
| /s/ Dr. Gerald Bailey | Independent Director | September 29, 2025 |
| Dr. Gerald Bailey | ||
| /s/ Peter N Christos | Independent Director | September 29, 2025 |
| Peter N. Christos | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.